Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

BROAD INSTITUTE

Filed by CROSSROADS STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-03 06:26:12 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
974b04ca-4e81-4663-83aa-4d6107459299
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

SCI · Science/Technology

General education about biomedical research and support for scientific funding. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. Federal policies related to OMB Uniform Guidance and their implications for federally funded biomedical research and research institutions. Federal science and technology policy, including OSTP priorities related to the future of federally supported research, scientific institutions, and national research capabilities.

BUD · Budget/Appropriations

General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. Support for the NIH All of Us Program. FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance.FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495).

Literal federal measure citations: H.R.9260, H.R.8800, S.4784, H.R.9495

MED · Medical/Disease Research/Clinical Labs

General education about biomedical research and support for scientific funding. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. Education and awareness regarding genetic medicines for rare and ultra-rare diseases.

DEF · Defense

Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance.FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495). Education and discussion regarding Broad Institute capabilities and technologies relevant to national biological intelligence, biosurveillance, and reconnaissance (ISR).

Literal federal measure citations: H.R.8800, S.4784, H.R.9495

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.